Norway
· Delayed Price · Currency is NOK Nordhealth AS Statistics
Total Valuation
Nordhealth AS has a market cap or net worth of NOK 3.16 billion. The enterprise value is 2.93 billion.
| Market Cap | 3.16B |
| Enterprise Value | 2.93B |
Important Dates
The next estimated earnings date is Tuesday, March 4, 2025.
| Earnings Date | Mar 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Nordhealth AS has 79.07 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 79.07M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 49.24% |
| Owned by Institutions (%) | 18.72% |
| Float | 38.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.16 |
| PB Ratio | 3.52 |
| P/TBV Ratio | 13.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -30.17 |
| EV / Sales | 5.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -41.35 |
Financial Position
The company has a current ratio of 3.06
| Current Ratio | 3.06 |
| Quick Ratio | 2.96 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -352.69 |
Financial Efficiency
Return on equity (ROE) is -10.05% and return on invested capital (ROIC) is -6.97%.
| Return on Equity (ROE) | -10.05% |
| Return on Assets (ROA) | -6.23% |
| Return on Capital (ROIC) | -6.97% |
| Revenue Per Employee | 1.27M |
| Profits Per Employee | -240,805 |
| Employee Count | 385 |
| Asset Turnover | 0.47 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +76.11% in the last 52 weeks. The beta is 0.54, so Nordhealth AS's price volatility has been lower than the market average.
| Beta (5Y) | 0.54 |
| 52-Week Price Change | +76.11% |
| 50-Day Moving Average | 38.28 |
| 200-Day Moving Average | 34.11 |
| Relative Strength Index (RSI) | 49.57 |
| Average Volume (20 Days) | 2,517 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Nordhealth AS had revenue of NOK 513.12 million and -97.04 million in losses. Loss per share was -1.23.
| Revenue | 513.12M |
| Gross Profit | 157.95M |
| Operating Income | -107.70M |
| Pretax Income | -93.40M |
| Net Income | -97.04M |
| EBITDA | -18.43M |
| EBIT | -107.70M |
| Loss Per Share | -1.23 |
Balance Sheet
| Cash & Cash Equivalents | 235.11M |
| Total Debt | n/a |
| Net Cash | 235.11M |
| Net Cash Per Share | 2.97 |
| Equity (Book Value) | 898.24M |
| Book Value Per Share | 11.36 |
| Working Capital | 220.30M |
Cash Flow
In the last 12 months, operating cash flow was -9.75 million and capital expenditures -61.05 million, giving a free cash flow of -70.80 million.
| Operating Cash Flow | -9.75M |
| Capital Expenditures | -61.05M |
| Free Cash Flow | -70.80M |
| FCF Per Share | -0.90 |
Margins
Gross margin is 30.78%, with operating and profit margins of -20.99% and -18.91%.
| Gross Margin | 30.78% |
| Operating Margin | -20.99% |
| Pretax Margin | -18.20% |
| Profit Margin | -18.91% |
| EBITDA Margin | -3.59% |
| EBIT Margin | -20.99% |
| FCF Margin | n/a |
Dividends & Yields
Nordhealth AS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |